South Asian participation in clinical trials: The views of lay people and health professionals

被引:60
|
作者
Hussain-Gambles, Mah [1 ]
Atkin, Karl [1 ]
Leese, Brenda [1 ]
机构
[1] Univ Leeds, Inst Hlth Sci & Publ Hlth Res, Ctr Res Primary Care, Leeds LS2 9PL, W Yorkshire, England
关键词
South Asian; clinical trials; participation; perspectives; health professionals; institutional racism; diversity and difference; recruitment strategies;
D O I
10.1016/j.healthpol.2005.07.022
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
There is little UK-based empirical research on South Asian participation in clinical trials. The predominantly US literature rarely engages with mainstream debates about ethnicity, diversity and difference. This study was prompted by a lack of knowledge about how South Asian people perceive trial involvement and the risks and benefits involved. Face to face interviews were conducted with 25 health professionals (consultants, GPs, nursing staff, academics, non-medically trained trial co-ordinators, LREC and MREC members) and 60 South Asian lay people (20 Indians, 20 Pakistanis and 20 Bangladeshis) who had not taken part in a trial. The study took place in the Leeds and Bradford areas of England. It was found that lay South Asian attitudes towards clinical trial participation focused on similarities rather than differences with the general UK population, suggesting that the relevance of ethnicity should be kept in perspective. There was no evidence of antipathy amongst South Asians to the concept of clinical trials, and awareness was a correlate of social class, education and younger age. Lay factors that might affect South Asian participation in clinical trials included: age; language, social class; feeling of not belonging/mistrust; culture and religion. Approachable patients (of the same gender, social class and fluent in English) tended to be 'cherry picked' to clinical trials. This practice was justified because of a lack of time, resources and inadequate support. South Asian patients might be systematically excluded from trials due to the increased cost and time associated with their inclusion, particularly in relation to the language barrier. Under-representation might also be due to passive exclusion associated with cultural stereotypes. The paper concludes by applying the theoretical framework of institutional racism as a means of making sense of policy and practice. At the same time, caution is advocated against using ethnicity as the only form of discrimination facing minority ethnic populations. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:149 / 165
页数:17
相关论文
共 50 条
  • [31] Preliminary development of a questionnaire measuring patient views of participation in clinical trials
    Arnetz, Judith
    Sudan, Sukhesh
    Goetz, Courtney
    Arnetz, Bengt
    Gowland, Laura
    Manji, Suzanne
    Ghosh, Samiran
    [J]. BMC RESEARCH NOTES, 2019, 12 (01)
  • [32] Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
    Victoire Leroy
    Wassim Gana
    Amal Aïdoud
    Jacques-Alexis N’kodo
    Anna-Chloé Balageas
    Pascal Blanc
    Dominique Bomia
    Camille Debacq
    Bertrand Fougère
    [J]. Alzheimer's Research & Therapy, 15
  • [33] Digital health technologies and Alzheimer's disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
    Leroy, Victoire
    Gana, Wassim
    Aidoud, Amal
    N'kodo, Jacques-Alexis
    Balageas, Anna-Chloe
    Blanc, Pascal
    Bomia, Dominique
    Debacq, Camille
    Fougere, Bertrand
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [34] Perceptions and barriers towards clinical trials participation in Asian cancer patients
    Soh, I. Peng Thomas
    Tay, Cheong Kiat Julian
    Ho, Gui Yi
    Pang, Angela
    Voon, Pei Jye
    Ling, Winnie Hui Yee
    Tan, Chee Seng
    Lee, Soo-Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Increasing Asian American participation in clinical trials by addressing community concerns
    Ma, Grace X.
    Seals, Brenda
    Tan, Yin
    Wang, Sylvia Y.
    Lee, Richard
    Fang, Carolyn Y.
    [J]. CLINICAL TRIALS, 2014, 11 (03) : 328 - 335
  • [36] Advance care planning for Maori, Pacific and Asian people: the views of New Zealand healthcare professionals
    Frey, Rosemary
    Raphael, Deborah
    Bellamy, Gary
    Gott, Merryn
    [J]. HEALTH & SOCIAL CARE IN THE COMMUNITY, 2014, 22 (03) : 290 - 299
  • [37] THE VIEWS OF ONCOLOGY PROFESSIONALS REGARDING THE VICTORIAN CANCER TRIALS LINK (VCTL), AN ONLINE CLINICAL TRIALS PORTAL
    Parker, Cat
    Jefford, Michael
    Millar, Jeremy
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 60 - 60
  • [38] The views of older people and health professionals about dignity in acute hospital care
    Tauber-Gilmore, Marcelle
    Addis, Gulen
    Zahran, Zainab
    Black, Sally
    Baillie, Lesley
    Procter, Sue
    Norton, Christine
    [J]. JOURNAL OF CLINICAL NURSING, 2018, 27 (1-2) : 223 - 234
  • [40] Promoting health of people with intellectual disabilities: Views of professionals working in group homes
    Wahlstrom, Lina
    Bergstrom, Helena
    Marttila, Anneli
    [J]. JOURNAL OF INTELLECTUAL DISABILITIES, 2014, 18 (02) : 113 - 128